A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gefitinib Impurity 4 | CAS 179688-52-9 - Request Quote

Picture of Gefitinib Impurity 4

Gefitinib Impurity 4

SZ CAT No:SZ-G018021
CAS No
179688-52-9
Mol.F.
C9H8N2O3 
Mol.Wt.
192.2
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gefitinib Impurity 4 is chemically 6-Hydroxy-7-methoxyquinazolin-4(1H)-one. Gefitinib Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 179688-52-9

Purchase 179688-52-9

Order 179688-52-9

Enquire 179688-52-9

price of 179688-52-9

179688-52-9 Supplier

179688-52-9 Manufacturer

179688-52-9 Exporter

buy high quality Gefitinib Impurity 4

Purchase Gefitinib Impurity 4

Gefitinib Impurity 4 suppliers

Gefitinib Impurity 4 manufacturers

Gefitinib Impurity 4 price

Order Gefitinib Impurity 4

Enquire Gefitinib Impurity 4

Gefitinib Impurity 4 cost

Gefitinib Impurity 4 Supplier

Gefitinib Impurity 4 Distributor

Gefitinib Impurity 4 for Method Validation

Gefitinib Reference Standard

Gefitinib Impurity 4 for ANDA Filing

Gefitinib Impurity 4 for Forced Degradation Studies

Gefitinib Impurity 4 Identification Standards

Gefitinib Impurity 4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,